Bachem Holding AG, Health Care sector

Bachem opens the week with sector tailwind, shares trade firmly on SIX

Veröffentlicht: 29.06.2026 um 12:34 Uhr, Redaktion AD HOC NEWS, Redaktionelle Verantwortung: Rafael Müller (Chefredaktion)

Bachem starts the new trading week with a firm stance on the SIX Swiss Exchange as Swiss healthcare peers show stable performance. Sector benchmarks and recent price action frame the stock’s position for retail investors.

Bachem Holding AG, Health Care sector, Swiss equities
Bachem Holding AG, Health Care sector, Swiss equities

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-29, 12:34.

Bachem Holding AG (CH1176493729) starts the new week with stable trading on the SIX Swiss Exchange and a clear position in the Swiss healthcare segment. The shares feature alongside other SPI health care constituents such as Lonza and Siegfried, according to sector overviews on MarketScreener and similar platforms.

What current data show

Recent quotations for Bachem on Swiss trading platforms place the shares in the low 70s Swiss francs, with bid indications around 73.18 francs and ask prices near 73.32 francs as of the latest morning snapshot, based on finanzen.ch data.finanzen.ch Bachem quote Parallel listings in euros for German trading venues show bid marks close to 79.45 euros and ask levels near 79.60 euros, offering a reference for cross-border investors using German-language portals.Finanzen100 Bachem profile

Sector and index context for the week

Bachem participates in the Swiss Performance Index (SPI) health care group, where peers such as Lonza and Roche help to set the tone for sentiment in life sciences exposure. According to current index composition details on MarketScreener, Bachem is tracked in the broader STXE 600 Health Care context, giving the stock visibility in European sector comparisons for fund managers and retail investors alike.MarketScreener Swiss health care view

Go deeper

Background and price data on Bachem

More articles, quotes and regulatory disclosures on Bachem shares are available in the dedicated topic section and on the company’s Investor Relations pages.

The business behind Bachem

Bachem generates revenue by manufacturing peptide-based active pharmaceutical ingredients and related services for the global pharmaceutical industry. The company’s catalog and custom synthesis offerings cover therapeutic peptides used in areas such as metabolic disorders and oncology, according to its public corporate profile and product range descriptions on the official website.

Where the Bachem shares trade today

The Bachem shares (CH1176493729) trade on the SIX Swiss Exchange at around 73.25 Swiss francs as of 2026-06-29, 12:34, based on recent intraday indications from Swiss quote services. This reference level places the stock broadly in line with the latest bid and ask marks cited on regional market portals.

Key data on the Bachem shares

  • Company: Bachem Holding AG
  • ISIN: CH1176493729
  • WKN: A3DLKE
  • Ticker: BHMN (SIX Swiss Exchange)
  • Trading venue: SIX Swiss Exchange
  • Price (as of 2026-06-29, 12:34): 73.25 CHF
  • Market cap: approximately 4.2 billion CHF (as of 2026-06-29)
  • Sector / industry: Health Care - Pharmaceuticals & Biotechnology
  • Index membership: SPI, STOXX Europe 600 Health Care
  • Next earnings date: not officially scheduled

More on the Bachem shares in social media

This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities. All data were obtained from sources deemed reliable but cannot be guaranteed. Investors should conduct their own research or consult a professional advisor before making investment decisions.

en | boerse | 69652319 |